VTE Flashcards

1
Q

What is Deep Vein Thrombosis?

A

A clot that forms in the deep veins of the legs or pelvis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is Pulmonary Embolus

A

A clot which arises atone site and travels via the blood stream is referred to as an embolus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is a thrombus?

A

Where a clot arises and remains in a particular place

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Define an embolus

A

Where a clot arises at one site and travel via the blood stream

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

State pharmacist role regarding VTE

A
Support safe care of patient by checking that appropriate treatment or chemoprophylaxis is given considering:
Clinical scenario: i.e VTE event or prophylaxis
Contra-indications and cautions
Choice of drug
Dose appropriate
Indication
Body weight
Renal function

Drug interactions
Intervene if necessary
Educate patient

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

State the cause of VTE

A

VTE is caused by a disturbance of the body’s normal blood clotting mechanism, principally due to
Vascular damage
Increased coagulability
Environment of slow blood flow

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

List the outcome of VTE

A
Morbidity
Acute
Long term complications
Recurrent VTE
Post thrombotic syndrome
Chronic pulmonary hypertension

Mortality
20% of patients can die within one hour of PE
45% within 30 days of a PE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the risk factors of VTE?

A
Personal history of VTE
Family history of VTE
Acute illness
Surgery
Immobility
Dehydration
Increasing age
Obesity
Smoking
Cancer
Male
Thrombophilia
Heart failure
Varicose viens
Pregnancy
OCP/HRT use
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

List the presentation of Pulmonary embolus

A
SOB
Chest pain
Cough  and haemoptysis
Hypotension
Tachycardia
Low grade fever
Any chest symptoms in patient with DVT symptoms
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

PE investigation and diagnosis

A

Full history taking and physical examination
CXR and ECG
CTPA - Computed tomography pulmonary angiography
Diagnostic test
Also helps arrive at diagnosis if PE not found
(VQ scan (scintigraphy))
Less reliable diagnostic test
D – dimer (product of fibrin degradation)
Non-specific but raises suspicion
Consider venous ultrasound scan to check for DVT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

DVT – investigation/diagnosis?

A

Full history taking and physical examination

Ultrasound imaging of veins (compression and doppler)
Diagnostic test

D – dimer (product of fibrin degradation)
Positive result; non-specific but raises suspicion
Negative result indicates no VTE
Can be used to prioritise patients for ultrasound

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

State the treatment of VTE

A

Anticoagulation
LMWH e.g. enoxaparin 1mg/kg BD (or 1.5mg/kg OD for uncomplicated patients with low risk of VTE recurrence)
minimum 5/7 and until oral anticoagulation established
Renal impairment – Enoxaparin sodium is not recommended for patients with end stage renal disease (creatinine clearance <15 mL/min) due to lack of data in this population outside the prevention of thrombus formation in extra corporeal circulation during haemodialysis.
If LMWH contraindicated due to degree of renal impairment or if high bleeding risk - UFH (unfractionated heparin infusion is needed) infusion adjusted to APTTr
Oral anticoagulant – 3/12 and review
Warfarin – dose adjusted according to INR
Or DOAC (NOACs) e.g. rivaroxaban, apixaban, edoxaban, dabigatran – check dose in BNF
Immediate onset of affect therefore no need for LMWH (except edoxaban)
Thrombolysis
Usually only for acute massive PE
Bleeding risk outweighed by prognosis of condition
Embolectomy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

DVT - Clinical presentation?

A
Typically a red, swollen & painful calf
Swelling and oedema
Pain and tenderness
Discolouration of the skin (redness, occasionally cyanosed)
Skin warm to the touch
Superficial venous distension
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

state the treatment for the following conditions:

Prophylaxis of Venous thromboembolic disease

Treatment of DVT and PE

Treatment of unstable angina and NSTEMI

treatment of acute STEMI (patients under 75)

treatment of acute STEMI (patients over 75)

A

Dosing regimen

2,000 IU (20 mg) SC once dally
100 IU\Kg (1 mg/kg) body weight SC once daily

100 IU/kg (1 mg/kg body weight SC once daily

I x 3,000 IU (30 mg) IV boos plus 100 IU/kg {1mg/kg) body weight SC and then 100 IU/kg (1 mg/kg) bodyweight SC every 24 hours

No IV initial bolus, 100 IU (1 mg/kg) body weight SC and then 100 IU/kg (1 mg/kg) body weight SC every 24 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Mechanical prophylaxis of VTE?

A

Anti-embolism stockings

Calf pumps “IPCC”

Geko device

IVC filter

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What dose of enoxaparin would you expect to be prescribed in each of the following situations?

80kg patient with extensive left leg DVT, GFR estimated at 72ml/min, no significant bleeding risks.

125kg patient admitted with right leg cellulitis, GFR 58ml/min, no significant bleeding risks.

47kg patient recently undergone repair of fractured neck of femur, GFR 35ml/min, no significant bleeding risks.

65kg patient admitted with GI bleed, GFR 92ml/min

60kg patient with bilateral PE (i.e. complicated PE), GFR 18ml/min, no significant bleeding risks.

A

solve the problem without an answer